Enovis (ENOV) vs PROCEPT BioRobotics (PRCT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Enovis (ENOV) has outperformed PROCEPT BioRobotics (PRCT) over the past year, losing 45.2% versus a loss of 48.5%. Over five years, PRCT leads with a -58.9% price change compared with -80.0% for ENOV. PROCEPT BioRobotics is the larger company by market cap ($1.02 billion vs $1.01 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ENOV | PRCT |
|---|---|---|
| Share price | $17.43 | $17.90 |
| Market cap | $1.01B | $1.02B |
| 1-day change | -1.02% | -0.06% |
| YTD return | -34.57% | -43.10% |
| 1-year return | -45.15% | -48.49% |
| 5-year return | -79.99% | -58.92% |
| Forward P/E | 4.85 | — |
| EPS (TTM) | $-19.23 | $-1.94 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $34.28 | $38.11 |
| 52-week low | $16.70 | $16.67 |
| Distance from 52-week high | -49.15% | -53.03% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +115.61% | +25.25% |
| Average volume | 1.45M | 1.44M |
| Shares outstanding | 57.67M | 56.92M |
| Employees | 7,802 | 888 |
| Sector | Healthcare | Health Care |
| Industry | Medical Devices | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Enovis in Healthcare and PROCEPT BioRobotics in Health Care.
About Enovis
ENOV stock →Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.
Healthcare · Medical Devices · 7,802 employees
About PROCEPT BioRobotics
PRCT stock →PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia.
Health Care · Medical/Dental Instruments · 888 employees
ENOV vs PRCT FAQ
Which is bigger, Enovis or PROCEPT BioRobotics?
PROCEPT BioRobotics (PRCT) is larger, with a market capitalization of $1.02B compared with $1.01B for Enovis (ENOV).
Which stock has performed better over the past year, ENOV or PRCT?
ENOV returned -45.15% over the past 12 months, compared with -48.49% for PRCT (price return, excluding dividends). Past performance does not predict future results.
Are Enovis and PROCEPT BioRobotics in the same industry?
No. Enovis is in the Healthcare sector, while PROCEPT BioRobotics is in Health Care.